Taking Newcastle to the world at BioJapan 2019

Senior Investment Manager Matt Bratton reflects on his time in Japan and the thriving life sciences sector in the North East of England.

Horizon Discovery divests animal models business to Envigo

• Animal model operations to be transferred to Envigo ownership • Divestment in line with Horizon’s corporate strategy to focus on its core markets • Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business • Horizon and Envigo to collaborate on providing CRISPR screening services

World Diabetes day 14th November 2019

World Diabetes Day (WDD) is a chance to celebrate how far we’ve come in research and look ahead to see what more can be done to raise awareness of the effects of diabetes and the actions patients and families can take to reduce its impact.

Sharon Grimster (ReNeuron) and Sarah Goulding (Knowledge Transfer Network) to be recognised at bioProcessUK conference

Sharon Grimster of ReNeuron and Dr Sarah Goulding of the Knowledge Transfer Network (KTN) will be awarded the prestigious Peter Dunnill award and Richard Wilson impact award respectively, at the UK BioIndustry Association’s (BIA) 16th bioProcessUK conference in Liverpool later this month.

CEO Update|Monday 11 November 2019

Great news for NHS patients this morning as two cannabis-based medicines - Epidyolex and Sativex, developed by BIA member GW Pharmaceuticals, have been approved for use by the NHS in England.

BIA launches biotech manifesto

The United Kingdom (UK) will have a general election on Thursday, 12 December. The UK BioIndustry Association (BIA) has today launched a biotech manifesto with its recommendations on how political parties can support the innovative UK life sciences sector.

PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development

Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies

Cognate BioServices announces acquisition of Cobra Biologics

- Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial products - EW Healthcare Partners and its co-investors provide the financing for the transaction

Is biotech bad news?

Is biotech bad news? That was the question asked of an expert panel of media and communications experts at the recent UK Bioscience Forum.

What does the General Election mean for BIA members?

“You’re joking!” as Brenda from Bristol might say. “Not ANOTHER one!” But here we are, only nine years since the Fixed Term Parliaments Act (FTPA) supposedly kept General Elections five years apart, heading to the polls for the third time in four years.